COVID-19 trials registries data warehouse

https://clinicaltrials.gov/show/NCT05308615

Erlina Burhan

Not reported

2022-04-04

Completed

RCT

Randomized

Parallel

Blind label

single-center

Prevention

inclusion criteria: age 18-65 years old human resources in persahabatan central general hospital while being a research subject wear ppe according to their respective work standards. not previously infected with covid-19, or have been infected with covid-19 19 previously with non-reactive igg serological results. have not received a covid-19 vaccine or have received 2nd dose of vaccine covid-19 but manifest non-reactive igg serological results subject voluntarily gave written consent to participate in this research.

patients with severe comorbid factors such as: uncontrolled congestive heart disease, renal insufficiency, coronary heart disease, chronic liver disease, diabetes mellitus with complications, uncontrolled hypertension or crisis hypertension, immunocompromised, cns disorders (such as stroke, epilepsy, alzheimer's, meningitis) , cancer, hiv, aids. subjects who are pregnant or breastfeeding. subjects who cannot be included in the study according to consideration of the researcher. subjects who are in the process of taking other drug clinical trials. subjects with a history of allergy to the components of the test drug.

2

Indonesia University

18

65

Indonesia

Healthy volunteers

N/A

92

The incidence of confirmed COVID-19 subjects from the results of PCR

None

Not reported

[{"arm_notes": "nan", "treatment_id": 2413, "treatment_name": "Rhea health tone", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]